Trial intelligence / Profile preview

O-GlcNAcylation Role in SLE Pathophysiology

NCT04440566Completed

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Oct 2020
Primary completion
Feb 2022
Countries
1
01

Overview

Single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Quantification of O-GlcNAcylation level in blood samples at Day 0. Started Oct 2020; status: completed.

Beyond the preview

Go deeper on NCT04440566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04440566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call